Free Trial

Tempus AI (NASDAQ:TEM) EVP Erik Phelps Sells 3,664 Shares

Tempus AI logo with Medical background

Key Points

  • Erik Phelps, the Executive Vice President of Tempus AI (NASDAQ:TEM), sold 3,664 shares at a price of $74.65, totaling approximately $273,518, reducing his ownership by 3.75%.
  • Tempus AI reported a 89.5% increase in quarterly revenue year-over-year, reaching $314.64 million, and exceeded EPS estimates by $0.01.
  • Several institutional investors, including ARK Investment Management and Vanguard Group, significantly increased their stakes in Tempus AI during the first quarter.
  • Want stock alerts on Tempus AI? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) EVP Erik Phelps sold 3,664 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $273,517.60. Following the completion of the sale, the executive vice president owned 94,115 shares in the company, valued at approximately $7,025,684.75. This trade represents a 3.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Erik Phelps also recently made the following trade(s):

  • On Monday, June 16th, Erik Phelps sold 51,317 shares of Tempus AI stock. The stock was sold at an average price of $72.56, for a total transaction of $3,723,561.52.

Tempus AI Trading Up 4.7%

TEM traded up $3.43 during mid-day trading on Thursday, hitting $76.71. The stock had a trading volume of 15,579,085 shares, compared to its average volume of 12,600,730. The stock's fifty day simple moving average is $63.48 and its 200-day simple moving average is $58.98. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The firm has a market capitalization of $13.33 billion, a price-to-earnings ratio of -64.46 and a beta of 4.98. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping the consensus estimate of ($0.23) by $0.01. The company had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The business's revenue for the quarter was up 89.5% compared to the same quarter last year. During the same period last year, the business posted ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Institutional Trading of Tempus AI

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. ARK Investment Management LLC raised its holdings in shares of Tempus AI by 35.9% in the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company's stock valued at $361,867,000 after purchasing an additional 1,981,755 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of Tempus AI by 6,247.5% in the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company's stock valued at $289,204,000 after purchasing an additional 5,900,668 shares during the last quarter. Nikko Asset Management Americas Inc. raised its holdings in shares of Tempus AI by 31.5% in the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company's stock valued at $205,401,000 after purchasing an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Finally, Frontier Capital Management Co. LLC raised its holdings in shares of Tempus AI by 236.2% in the fourth quarter. Frontier Capital Management Co. LLC now owns 943,718 shares of the company's stock valued at $31,860,000 after purchasing an additional 663,018 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have commented on TEM. Morgan Stanley raised their target price on shares of Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a report on Tuesday, August 12th. BTIG Research raised their target price on shares of Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a report on Wednesday. Piper Sandler restated a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Needham & Company LLC restated a "buy" rating and set a $70.00 target price on shares of Tempus AI in a report on Friday, August 8th. Finally, Guggenheim raised their target price on shares of Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a report on Monday, June 30th. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $67.64.

Read Our Latest Research Report on TEM

Tempus AI Company Profile

(Get Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Featured Articles

Insider Buying and Selling by Quarter for Tempus AI (NASDAQ:TEM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tempus AI Right Now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Next Tech Boom: AI Robots Are Coming Sooner Than You Think!
Tech Stocks Stumble: Will Nvidia’s Report Spark a Rebound?
Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines